Electric pulses zap thyroid cancer in neck lymph nodes in new trial
NCT ID NCT07328243
First seen Jan 11, 2026 · Last updated Jun 14, 2026 · Updated 27 times
Summary
This study tests a procedure called irreversible electroporation (IRE) for thyroid cancer that has come back in neck lymph nodes after surgery. IRE uses short, strong electric pulses to destroy cancer cells without cutting. About 85 adults will receive one or two IRE treatments and be followed for 2 years to see if the treated lymph nodes shrink and if quality of life improves.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPH NODE METASTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 79 Qingchun Road, Shangcheng District
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.